+21% CAGR for Single-Use Bioreactors Market to Exhibit $US1,085.7m by 2021

In this report, the single-use bioreactors market is broadly segmented on the basis of product type, cell type, technology, application, end user, and region with n-depth assessment of market strategies, product portfolios, and manufacturing capabilities of the leading players in the global single-use bioreactors market

The global single-use bioreactors market is projected to reach USD 1,085.7 million by 2021 from USD 408.4 million in 2016, growing at a CAGR of 21.6% during the forecast period (2016–2021). Factors such as improved return on investment for small companies and startups, reduced complexity in automation, and positive impact on the environment are driving the growth of the single-use bioreactors market.

Complete report on single-use bioreactors market spread across 148 pages, profiling 10 companies and supported with 115 tables and 55 figures is now available at http://www.rnrmarketresearch.com/single-use-bioreactor-market-by-product-stem-cells-interferons-cell-yeast-plant-cells-technology-bubble-column-bioreactors-application-r-d-bioproduction-end-user-r-d-department-biopharmaceutical-man-st-to-2021-market-report.html .

On the basis of cell type, the single-use bioreactors market is categorized into mammalian cells, bacteria, yeast, and other cells (insect and plant cells). In 2016, the monoclonal antibodies segment is expected to account for the largest share of the single-use bioreactors market. Factors such as reduced risk of contamination and easy implementation in bio production are driving the adoption of SUBs for the production of these molecules. Based on technology, the single-use bioreactors market is categorized into wave-induced motion SUBs, stirred SUBs, single-use bubble column bioreactors, and others technologies. The wave-induced motion SUBs segment is expected to account for the largest market share in 2016. Growth in this segment can be attributed to the advantages offered by this technology such as high flexibility and shorter lead times.

Europe is expected to account for the largest share of the single-use bioreactors market in 2016. Patent cliff of many biologics drugs in Europe and government support for pharmaceutical companies to launch new biologics therapies with superior efficacy are driving the growth of the single-use bioreactors market in this region. The APAC single-use bioreactors market is expected to register the highest CAGR of 23.4% in the next five years. The rapidly growing healthcare industry and increasing investments by major pharmaceutical companies in this region are contributing to the high growth of the APAC single-use bioreactors market during the forecast period.

Product launches was the most widely adopted growth strategy pursued by players in the single-use bioreactors market, to increase their shares and cater to the unmet needs. The major players operating in the single-use bioreactors market include Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), GE Healthcare (U.S.), Danaher Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.). Request a discount before order a copy of Single-use Bioreactor Market by Product (Stem cells, Interferons), Cell (Yeast, Plant cells), Technology (Bubble column bioreactors), Application (R&D, Bioproduction), End User (R&D department, Biopharmaceutical manufacturers) - Global Forecast to 2021 research report at http://www.rnrmarketresearch.com/contacts/discount?rname=708352 .

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

On a related note, another research on Bioreactors Market by Scale Range, Usage, Material, Suppliers, End-User and Region - Global Forecast to 2021 says, a number of facilities with small-scale systems are being built in favor of single-use bioreactors. The global market is expected to reach to USD 1,417 million by 2021 from USD 955 million in 2015, at a CAGR of 6.8% between 2015 and 2021. Companies like Sartorius AG, Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG and more have been profiled in this 115 pages research report available at http://www.rnrmarketresearch.com/bioreactors-market-by-scale-range-20l-1500l-material-single-use-stainless-steel-usage-lab-scale-pilot-scale-full-scale-suppliers-oems-epcs-end-user-r-d-departments-biopharmaceutical-manufacturers-st-to-2021-market-report.html .

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: RnR Market Research
Address: 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001 Maharashtra, India.
Phone: +1-888-391-5441
Website: http://www.rnrmarketresearch.com

Release ID: 136274